{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:46Z","timestamp":1786980346399,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetic kidney disease is the leading cause of end-stage kidney disease in high-income countries. The strict control of glycemic oscillations is the principal therapeutic target, but this could be hard to achieve in uremic patients due to their unpredictable insulin sensitivity. Currently, the evaluation of the glycemic profile relies on serum markers (glycated hemoglobin HbA1c, glycated albumin, and fructosamine), capillary glucose blood control (self-monitoring of blood glucose), and interstitial glucose control (continue glucose monitoring). We conducted a systematic review of published articles on continue glucose monitoring in hemodialysis patients with type 2 diabetes, which included 12 major articles.\nFour studies found significant fluctuations in glucose levels during hemodialysis sessions. All studies reported a higher mean amplitude of glucose variations on the hemodialysis day. Three studies agreed that continue glucose monitoring is better than glycated hemoglobin in detecting these abnormalities. Moreover, continue glucose monitoring was more accurate and perceived as easier to use by patients and their caregivers. In patients with type 2 diabetes on hemodialysis, glucose levels show different variation patterns than the patients on hemodialysis without diabetes. Considering manageability, accuracy, and cost-effectiveness, continue glucose monitoring could be the ideal diagnostic tool for the patient with diabetes on hemodialysis.<\/jats:p>","DOI":"10.1007\/s00592-021-01699-6","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T05:02:46Z","timestamp":1616216566000},"page":"975-981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2011-2160","authenticated-orcid":false,"given":"Maurizio","family":"Gallieni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"De Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Lunati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D\u2019Addio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Sabiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Miglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Vincenzo","family":"Zuccotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1093-7724","authenticated-orcid":false,"given":"Paolo","family":"Fiorina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"key":"1699_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13293-019-0277-z","volume":"11","author":"R de Ritter","year":"2020","unstructured":"de Ritter R, de Jong M, Vos RC et al (2020) Sex differences in the risk of vascular disease associated with diabetes. Biol Sex Differ 11:1","journal-title":"Biol Sex Differ"},{"key":"1699_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000177322","volume":"88","author":"E Astorri","year":"1997","unstructured":"Astorri E, Fiorina P, Gavaruzzi G, Astorri A, Magnati G (1997) Left ventricular function in insulin-dependent and in non-insulin-dependent diabetic patients: radionuclide assessment. Cardiology 88:152\u2013155","journal-title":"Cardiology"},{"key":"1699_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11892-011-0211-1","volume":"11","author":"R Bassi","year":"2011","unstructured":"Bassi R, Fiorina P (2011) Impact of islet transplantation on diabetes complications and quality of life. Curr Diab Rep 11:355\u2013363","journal-title":"Curr Diab Rep"},{"key":"1699_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.stem.2015.07.010","volume":"17","author":"F D'Addio","year":"2015","unstructured":"D\u2019Addio F, La Rosa S, Maestroni A et al (2015) Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy. Cell Stem Cell 17:486\u2013498","journal-title":"Cell Stem Cell"},{"key":"1699_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0140-6736(96)91246-5","volume":"347","author":"P Fiorina","year":"1996","unstructured":"Fiorina P, Lattuada G, Ponari O, Silvestrini C, DallAglio P (1996) Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet 347:692\u2013693","journal-title":"Lancet"},{"key":"1699_CR6","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1681\/ASN.2013050518","volume":"25","author":"P Fiorina","year":"2014","unstructured":"Fiorina P, Vergani A, Bassi R et al (2014) Role of podocyte B7\u20131 in diabetic nephropathy. J Am Soc Nephrol 25:1415\u20131429","journal-title":"J Am Soc Nephrol"},{"key":"1699_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jacc.2005.05.075","volume":"46","author":"G Perseghin","year":"2005","unstructured":"Perseghin G, Fiorina P, De Cobelli F et al (2005) Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. J Am Coll Cardiol 46:1085\u20131092","journal-title":"J Am Coll Cardiol"},{"key":"1699_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2522\/ptj.20080020","volume":"88","author":"AD Deshpande","year":"2008","unstructured":"Deshpande AD, Harris-Hayes M, Schootman M (2008) Epidemiology of diabetes and diabetes-related complications. Phys Ther 88:1254\u20131264","journal-title":"Phys Ther"},{"key":"1699_CR9","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jacc.2008.09.055","volume":"53","author":"G Orasanu","year":"2009","unstructured":"Orasanu G, Plutzky J (2009) The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 53:S35-42","journal-title":"J Am Coll Cardiol"},{"key":"1699_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12967-019-2016-y","volume":"17","author":"G Wang","year":"2019","unstructured":"Wang G, Ouyang J, Li S et al (2019) The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases. J Transl Med 17:264","journal-title":"J Transl Med"},{"key":"1699_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0041-1345(02)03879-4","volume":"35","author":"G Randhawa","year":"2003","unstructured":"Randhawa G (2003) Developing culturally competent renal services in the United Kingdom: tackling inequalities in health. Transplant Proc 35:21\u201323","journal-title":"Transplant Proc"},{"key":"1699_CR12","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1001\/archinternmed.2011.537","volume":"171","author":"S Shurraw","year":"2011","unstructured":"Shurraw S, Hemmelgarn B, Lin M et al (2011) Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med 171:1920\u20131927","journal-title":"Arch Intern Med"},{"key":"1699_CR13","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1161\/CIRCULATIONAHA.109.857268","volume":"120","author":"C Drechsler","year":"2009","unstructured":"Drechsler C, Krane V, Ritz E, Marz W, Wanner C (2009) Glycemic control and cardiovascular events in diabetic hemodialysis patients. Circulation 120:2421\u20132428","journal-title":"Circulation"},{"key":"1699_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0079-6123(02)39025-3","volume":"139","author":"KC Abbott","year":"2002","unstructured":"Abbott KC, Bakris GL (2002) Treatment of the diabetic patient: focus on cardiovascular and renal risk reduction. Prog Brain Res 139:289\u2013298","journal-title":"Prog Brain Res"},{"key":"1699_CR15","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.2337\/diabetes.53.9.2291","volume":"53","author":"P Fiorina","year":"2004","unstructured":"Fiorina P, Folli F, D\u2019Angelo A et al (2004) Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes 53:2291\u20132300","journal-title":"Diabetes"},{"key":"1699_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0026-0495(86)90034-X","volume":"35","author":"F Folli","year":"1986","unstructured":"Folli F, Sinha MK, Brancaccio D, Caro JF (1986) Insulin resistance in uremia: in vitro model in the rat liver using human serum to study mechanisms. Metabolism 35:989\u2013998","journal-title":"Metabolism"},{"key":"1699_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2337\/diacare.16.1.178","volume":"16","author":"F Pellegatta","year":"1993","unstructured":"Pellegatta F, Folli F, Ronchi P, Caspani L, Galli L, Vicari AM (1993) Deranged platelet calcium homeostasis in poorly controlled IDDM patients. Diabetes Care 16:178\u2013183","journal-title":"Diabetes Care"},{"key":"1699_CR18","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1161\/01.ATV.14.9.1420","volume":"14","author":"AM Vicari","year":"1994","unstructured":"Vicari AM, Monzani ML, Pellegatta F, Ronchi P, Galli L, Folli F (1994) Platelet calcium homeostasis is abnormal in patients with severe arteriosclerosis. Arterioscler Thromb 14:1420\u20131424","journal-title":"Arterioscler Thromb"},{"key":"1699_CR19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.2337\/diacare.19.10.1062","volume":"19","author":"AM Vicari","year":"1996","unstructured":"Vicari AM, Taglietti MV, Pellegatta F et al (1996) Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. a possible link to increased cardiovascular mortality? Diabetes Care 19:1062\u20136","journal-title":"Diabetes Care"},{"key":"1699_CR20","doi-asserted-by":"publisher","first-page":"329606","DOI":"10.1155\/2013\/329606","volume":"2013","author":"JL Bailey","year":"2013","unstructured":"Bailey JL (2013) Insulin resistance and muscle metabolism in chronic kidney disease. ISRN Endocrinol 2013:329606","journal-title":"ISRN Endocrinol"},{"key":"1699_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000186953","volume":"61","author":"RH Mak","year":"1992","unstructured":"Mak RH, DeFronzo RA (1992) Glucose and insulin metabolism in uremia. Nephron 61:377\u2013382","journal-title":"Nephron"},{"key":"1699_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s005920200010","volume":"39","author":"KF Lee","year":"2002","unstructured":"Lee KF, Szeto YT, Benzie IF (2002) Glycohaemoglobin measurement: methodological differences in relation to interference by urea. Acta Diabetol 39:35\u201339","journal-title":"Acta Diabetol"},{"key":"1699_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1542-4758.2011.00640.x","volume":"16","author":"T Ogawa","year":"2012","unstructured":"Ogawa T, Murakawa M, Matsuda A et al (2012) Endogenous factors modified by hemodialysis may interfere with the accuracy of blood glucose-measuring device. Hemodial Int 16:266\u2013273","journal-title":"Hemodial Int"},{"key":"1699_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000362863","volume":"38","author":"M Gai","year":"2014","unstructured":"Gai M, Merlo I, Dellepiane S et al (2014) Glycemic pattern in diabetic patients on hemodialysis: continuous glucose monitoring (CGM) analysis. Blood Purif 38:68\u201373","journal-title":"Blood Purif"},{"key":"1699_CR25","doi-asserted-by":"publisher","first-page":"10936","DOI":"10.3390\/s101210936","volume":"10","author":"P Rossetti","year":"2010","unstructured":"Rossetti P, Bondia J, Vehi J, Fanelli CG (2010) Estimating plasma glucose from interstitial glucose: the issue of calibration algorithms in commercial continuous glucose monitoring devices. Sensors (Basel) 10:10936\u201310952","journal-title":"Sensors (Basel)"},{"key":"1699_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1932296816662047","volume":"11","author":"F Reiterer","year":"2017","unstructured":"Reiterer F, Polterauer P, Schoemaker M et al (2017) Significance and reliability of MARD for the accuracy of CGM systems. J Diabetes Sci Technol 11:59\u201367","journal-title":"J Diabetes Sci Technol"},{"key":"1699_CR27","first-page":"54","volume":"30","author":"T Mori","year":"2014","unstructured":"Mori T, Chida M, Oba I et al (2014) Diurnal variations of blood glucose by continuous blood glucose monitoring in peritoneal dialysis patients with diabetes. Adv Perit Dial 30:54\u201359","journal-title":"Adv Perit Dial"},{"key":"1699_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.diabres.2016.10.016","volume":"122","author":"T Yajima","year":"2016","unstructured":"Yajima T, Yajima K, Hayashi M, Takahashi H, Yasuda K (2016) Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring. Diabetes Res Clin Pract 122:78\u201383","journal-title":"Diabetes Res Clin Pract"},{"key":"1699_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1055\/s-0034-1370963","volume":"46","author":"F Chantrel","year":"2014","unstructured":"Chantrel F, Sissoko H, Kepenekian L et al (2014) Influence of dialysis on the glucose profile in patients with diabetes: usefulness of continuous glucose monitoring. Horm Metab Res 46:810\u2013813","journal-title":"Horm Metab Res"},{"key":"1699_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000485843","volume":"47","author":"M Divani","year":"2018","unstructured":"Divani M, Georgianos PI, Didangelos T et al (2018) Comparison of glycemic markers in chronic hemodialysis using continuous glucose monitoring. Am J Nephrol 47:21\u201329","journal-title":"Am J Nephrol"},{"key":"1699_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jdiacomp.2014.12.015","volume":"29","author":"YP Jin","year":"2015","unstructured":"Jin YP, Su XF, Yin GP et al (2015) Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy. J Diabetes Complications 29:395\u2013399","journal-title":"J Diabetes Complications"},{"key":"1699_CR32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.diabres.2015.01.026","volume":"107","author":"M Joubert","year":"2015","unstructured":"Joubert M, Fourmy C, Henri P, Ficheux M, Lobbedez T, Reznik Y (2015) Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study. Diabetes Res Clin Pract 107:348\u2013354","journal-title":"Diabetes Res Clin Pract"},{"key":"1699_CR33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1089\/dia.2010.0067","volume":"12","author":"HS Jung","year":"2010","unstructured":"Jung HS, Kim HI, Kim MJ et al (2010) Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system. Diabetes Technol Ther 12:801\u2013807","journal-title":"Diabetes Technol Ther"},{"key":"1699_CR34","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2337\/dc08-1688","volume":"32","author":"S Kazempour-Ardebili","year":"2009","unstructured":"Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T et al (2009) Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care 32:1137\u20131142","journal-title":"Diabetes Care"},{"key":"1699_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5414\/CN108280","volume":"82","author":"L Kepenekian","year":"2014","unstructured":"Kepenekian L, Smagala A, Meyer L et al (2014) Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study. Clin Nephrol 82:240\u2013246","journal-title":"Clin Nephrol"},{"key":"1699_CR36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1089\/dia.2010.0052","volume":"12","author":"M Mirani","year":"2010","unstructured":"Mirani M, Berra C, Finazzi S et al (2010) Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis. Diabetes Technol Ther 12:749\u2013753","journal-title":"Diabetes Technol Ther"},{"key":"1699_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1932296818818429","volume":"13","author":"K Mori","year":"2019","unstructured":"Mori K, Emoto M, Abe M, Inaba M (2019) Visualization of blood glucose fluctuations using continuous glucose monitoring in patients undergoing hemodialysis. J Diabetes Sci Technol 13:413\u2013414","journal-title":"J Diabetes Sci Technol"},{"key":"1699_CR38","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/ndt\/gfp181","volume":"24","author":"JP Riveline","year":"2009","unstructured":"Riveline JP, Teynie J, Belmouaz S et al (2009) Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant 24:2866\u20132871","journal-title":"Nephrol Dial Transplant"},{"key":"1699_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/1932296819882690","volume":"14","author":"T Yajima","year":"2020","unstructured":"Yajima T, Takahashi H, Yasuda K (2020) Comparison of Interstitial Fluid Glucose Levels Obtained by Continuous Glucose Monitoring and Flash Glucose Monitoring in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis. J Diabetes Sci Technol 14:1088\u20131094","journal-title":"J Diabetes Sci Technol"},{"key":"1699_CR40","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00592-019-01323-8","volume":"56","author":"C Berra","year":"2019","unstructured":"Berra C, De Fazio F, Azzolini E et al (2019) Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population. Acta Diabetol 56:931\u2013938","journal-title":"Acta Diabetol"},{"key":"1699_CR41","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00592-014-0598-7","volume":"51","author":"E Hommel","year":"2014","unstructured":"Hommel E, Olsen B, Battelino T et al (2014) Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol 51:845\u2013851","journal-title":"Acta Diabetol"},{"key":"1699_CR42","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2337\/dc17-1821","volume":"41","author":"W Wan","year":"2018","unstructured":"Wan W, Skandari MR, Minc A et al (2018) Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial. Diabetes Care 41:1227\u20131234","journal-title":"Diabetes Care"},{"key":"1699_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1177\/1932296815578716","volume":"9","author":"S Pleus","year":"2015","unstructured":"Pleus S, Schoemaker M, Morgenstern K et al (2015) Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings. J Diabetes Sci Technol 9:801\u2013807","journal-title":"J Diabetes Sci Technol"},{"key":"1699_CR44","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1177\/1932296814541810","volume":"8","author":"D Rodbard","year":"2014","unstructured":"Rodbard D (2014) Characterizing accuracy and precision of glucose sensors and meters. J Diabetes Sci Technol 8:980\u2013985","journal-title":"J Diabetes Sci Technol"},{"key":"1699_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.numecd.2018.01.003","volume":"28","author":"F Boscari","year":"2018","unstructured":"Boscari F, Galasso S, Acciaroli G et al (2018) Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile. Nutr Metab Cardiovasc Dis 28:425\u2013427","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-021-01699-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-021-01699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:25:38Z","timestamp":1675038338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-021-01699-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1699"],"URL":"https:\/\/doi.org\/10.1007\/s00592-021-01699-6","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"28 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}